Synonyms: BI-397 | BI397 | Dalvance® | Xydalba®
dalbavancin is an approved drug (FDA (2014), EMA (2015))
Compound class:
Synthetic organic
Comment: Dalbavancin is a second-generation, semi-synthetic lipoglycopeptide antibacterial [1-2]. It has been modified to increase activity and allow once-weekly dosing. Dalbavancin inhibits cross-linking of bacterial cell wall peptidoglycans, and thereby disrupts bacterial cell wall synthesis. It has little activity against Gram-negative bacilli [3].
|
|
No information available. |
External links ![]() |
For extended ADME data see the following: Drugs.com European Medicines Agency (EMA) |